Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
FDA Requiring Stronger Safety Labels for Opioid Medications
MONDAY, Aug. 4, 2025 -- The U.S. Food and Drug Administration announced it will now be requiring updated safety labels for all opioid pain medications to...
Study Offers Comprehensive Evaluation of Survival Parameters for Pediatric CNS Tumors
MONDAY, Aug. 4, 2025 -- The survival probabilities of pediatric central nervous system (CNS) tumors in Europe have been explored in a study published in the...
CVD Mortality Varies Among Asian Indian, Chinese, Filipino Americans
MONDAY, Aug. 4, 2025 -- Cardiovascular risk factor and disease mortality varies significantly among Asian Indian, Chinese, and Filipino Americans, with...
Preconception Hypoglycemia Linked to Adverse Pregnancy Outcomes
MONDAY, Aug. 4, 2025 -- Preconception hypoglycemia is associated with adverse pregnancy outcomes, according to a study published online July 29 in PLOS...
Rapid Treatment Needed to Reduce Mortality From Flu-Linked Acute Necrotizing Encephalopathy in Children
MONDAY, Aug. 4, 2025 -- Influenza-associated acute necrotizing encephalopathy (ANE) in children is associated with high morbidity and mortality, according to a...
Mental Illness Increased During, After Pregnancy for Gestational Carriers
MONDAY, Aug. 4, 2025 -- Gestational carriers seem to be more likely to be diagnosed with mental illness during and after pregnancy than those with unassisted...
Freeze-Dried Fruit Recalled From Sam’s Club Over Listeria Risk
MONDAY, Aug. 4, 2025 — Popular freeze-dried fruit snacks sold at Sam’s Club are being recalled because of possible listeria contamination. Doehler...
Couple Welcomes Baby From 1994 Embryo in Rare ‘Embryo Adoption’
MONDAY, Aug. 4, 2025 — An Ohio couple has welcomed a healthy baby boy from an embryo frozen for more than three decades, setting what doctors believe is...
Presidential Fitness Test Returns to U.S. Schools
MONDAY, Aug. 4, 2025 — The Presidential Fitness Test is returning to U.S. schools after more than a decade. President Donald Trump signed an executive...
MS May Begin Years Earlier Than Thought
MONDAY, Aug. 4, 2025 — People with multiple sclerosis (MS) begin experiencing new health issues up to 15 years before the classic signs of the illness...
FDA Approves Vostally (ramipril) Oral Solution for the Treatment of Hypertension in Adults
Greenville, SC – July 31, 2025 – Rosemont Pharmaceuticals, Inc. announced that on July 23, 2025, the U.S. Food and Drug Administration (FDA) has...
FDA Approves Vizz (aceclidine ophthalmic solution) for the Treatment of Presbyopia
SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), today announced the US...
FDA Approves Alhemo as Once-Daily Prophylactic Treatment to Prevent or Reduce the Frequency of Bleeding Episodes for Adults and Children 12 Years of Age and Older with Hemophilia A or B (HA/HB) Without Inhibitors
PLAINSBORO, N.J., July 31, 2025 /PRNewswire/ -- Novo Nordisk announced today that the US Food and Drug Administration (FDA) approved Alhemo (concizumab-mtci)...
Novartis' Twice-Yearly Leqvio (inclisiran) Receives FDA Approval for New Indication Enabling First-Line Use
EAST HANOVER, N.J., July 31, 2025 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has approved a label update for...
US FDA Approves New Biktarvy Indication For People With HIV Who Are Treatment Experienced And Restarting Antiretroviral Treatment
Foster City, Calif., July 30, 2025 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted a...
Pierre Fabre Pharmaceuticals Inc. Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Tabelecleucel for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
SECAUCUS, N.J., July 24, 2025 /PRNewswire/ -- Pierre Fabre Pharmaceuticals Inc. (PFP) announces the acceptance by U.S. Food and Drug Administration (FDA) of...
Replimune Receives Complete Response Letter from FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
WOBURN, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of...
Johnson & Johnson Seeks First Icotrokinra U.S. FDA Approval Aiming to Revolutionize Treatment Paradigm for Adults and Adolescents with Plaque Psoriasis
SPRING HOUSE, Pa. (July 21, 2025) – Johnson & Johnson (NYSE: JNJ) today announced the submission of a New Drug Application (NDA) to the U.S. Food...
Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease
LEXINGTON, Mass.--(BUSINESS WIRE)--Jul. 17, 2025-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug...
Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Jul. 14, 2025-- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery...
Allogene Therapeutics Moves Forward with Standard Fludarabine and Cyclophosphamide (FC) Lymphodepletion Regimen in the ALPHA3 Trial for Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation for Large B-Cell Lymphoma
SOUTH SAN FRANCISCO, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...
Sanofi’s SAR446523, a GPRC5D Monoclonal Antibody, Earns Orphan Drug Designation in the US for Multiple Myeloma
Paris, July 30, 2025. The US Food and Drug Administration (FDA) has granted orphan drug designation to SAR446523, an IgG1-based Antibody-Dependent Cellular...
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Severe-to-Very Severe Alopecia Areata
SAN FRANCISCO, July 29, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted...
Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma
SAN DIEGO, July 29, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a...
Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD)
HUNTSVILLE, AL, July 29, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology...
Browse by news type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Drugs.com Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Disclaimer
This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.